Molecular PsychiatryGenetic & Genomic MedicinePeer-reviewed journal article
Whats in a diagnosis? A genetic decomposition of major depression.
Bradley S. JermyiD, Kylie P. GlanvilleiD, Jonathan R. I. ColemaniD, Cathryn M. LewisiD, Evangelos VassosiD
Abstract
Determining a diagnosis of major depressive disorder (MDD) is complex, involving consideration and rating of a variety of different components. These include number of symptoms over an agreed threshold, symptom duration, functional impairment, persistence of symptoms within an episode, and symptom recurrence. While these components are generally accepted amongst physicians, it is unknown whether they reflect partly distinct biology between phenotypes. The aim of this study was to investigate how the genetic aetiology varies in the presence of different MDD components. Thirty-two depression phenotypes which systematically incorporate the MDD components were created using the mental health questionnaire data within the UK Biobank. SNP-based heritabilities and genetic correlations with three previously defined major depression phenotypes were calculated (broad depression, Psychiatric Genomics Consortium (PGC) defined depression and 23andMe, Inc. self-reported depression) and differences between estimates analysed. All phenotypes were heritable (h2SNP range: 0.102 - 0.162) and showed substantial genetic correlations with other major depression phenotypes (Rg range: 0.651 - 0.894 (PGC); 0.652 - 0.837 (23andMe); 0.699 - 0.900 (broad depression)). The requirement for 5 or more symptoms and for a long episode duration had the strongest effect on SNP-based heritability, in the positive and negative direction respectively (1.4% average increase; 2.7% average decrease). No significant differences were noted between genetic correlations. While there is some variation, the two cardinal symptoms, depressed mood and anhedonia, largely reflect the genetic aetiology of phenotypes incorporating more MDD components. These components may appropriately index for severity, however, the genetic component between phenotypes incorporating none and all components is comparable.
- organism: human
- assay: GWAS summary statistics
- research focus: GWAS / association mapping
- approach: statistical model
- Citations
- 39
- FWCI
- 3.67
- Field percentile
- top 6%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Investigating Genetic Heterogeneity in Major Depression Through Item-level Genetic Analyses of the PHQ-9
Jackson G. Thorp, Andries T. Marees, … Eske M. Derks·Psychological MedicinePeer-reviewed·Sep 18, 2019
- Minimal phenotyping yields GWAS hits of reduced specificity for major depression
Na Cai, Joana A. Revez, … Jonathan Flint C·bioRxiv·Nov 4, 2019
- Genetic structure of major depression symptoms across clinical and community cohorts
Mark J. Adams, Jackson G. Thorp, … Eske M. Derks·medRxiv·Jul 5, 2023
- Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression
eQTLGen, Naomi R. Wray, … Niamh Mullins·Nature GeneticsPeer-reviewed·Apr 26, 2018
- Multiple measures of depression to enhance validity of Major Depressive Disorder in the UK Biobank
Kylie P. Glanville, Jonathan R. I. Coleman, … Cathryn M. Lewis·BJPsych OpenPeer-reviewed·Feb 5, 2021
- Polygenic analyses show important differences between MDD symptoms collected using PHQ9 and CIDI-SF
Lianyun Huang, Sonja N. Tang, … Na Cai·Biological PsychiatryPeer-reviewed·Dec 4, 2023